About Life Sciences Review Europe

Life Sciences Review Europe (Print ISSN 2831-8323 | Digital ISSN 2831-8331) is an industry magazine focused on the European life sciences industry, helping organizations navigate a complex landscape shaped by scientific innovation, regulatory rigor, and evolving market dynamics. Founded in 2020, the magazine reaches over 83,000 quality subscribers across Europe.

At its core, Life Sciences Review Europe operates as a peer-driven platform where industry leaders and decision-makers share real-world insights, challenges, and strategies. The publication emphasizes practical, experience-led perspectives, offering a grounded view of how organizations across pharmaceuticals, biotechnology, medical devices, and diagnostics are adapting to shifting demands and advancing innovation.

OUR Mission

Life Sciences Review Europe aims to empower organizations and industry leaders to make informed decisions on the technologies, strategies, and solutions shaping the future of life sciences. As a knowledge-sharing platform, it bridges the gap between enterprises, solution providers, and stakeholders working to drive scientific progress, efficiency, and regulatory excellence.

Editorial Focus and Coverage

Life Sciences Review Europe features perspectives from executives, researchers, and operational leaders on how organizations evaluate, adopt, and scale solutions across the life sciences ecosystem. The publication covers key areas such as compliance, regulatory affairs, analytics, product design and development, testing and validation, clinical operations, toxicology services, supply chain management, and training.

Alongside leadership insights, the magazine highlights organizations delivering impactful solutions across life sciences technologies and services. Companies are identified through a structured methodology, involving nominations from the publication’s subscriber network across Europe, combined with editorial research and insights from an industry advisory panel, ensuring a credible and balanced view of the evolving ecosystem.

As the industry undergoes a shift toward more specialized, digital, and integrated models, driven by cost pressures, scientific breakthroughs, and changing demographics, Life Sciences Review Europe captures how organizations are building agility and resilience while maintaining a focus on innovation and patient impact.

With editorial offices in London, UK; Fremont, CA; Fort Lauderdale, FL; Toronto, Canada; Brasilia, Brazil; and Singapore, Life Sciences Review Europe brings a global perspective to the developments shaping the life sciences industry.

Who Contributes to Life Sciences Review Europe

150+ CXOs and senior leaders from public enterprises
750+ CXOs and senior leaders from private companies
Industry leaders responsible for research, clinical operations, regulatory compliance, product development, analytics, and strategic innovation

These contributors include executives, scientists, and operational leaders who bring firsthand experience and practical insight into the evolving life sciences landscape. Their perspectives reflect individual expertise and are intended to inform broader industry conversations.

Editorial Policy and Standards

Life Sciences Review Europe maintains a contributor-driven, insight-focused editorial policy. The publication emphasizes accuracy, clarity, and practical relevance for decision-makers, while presenting a balanced mix of expert commentary and curated industry perspectives. This ensures readers can engage with the content confidently and understand its context within the broader life sciences ecosystem.

Select Recognized Company Testimonials

Rodi Fertility

“Being featured on the cover of Life Sciences Review Europe and showcased through a dedicated article was an outstanding experience for RODI Fertility’s patented technology. The team captured our innovation with exceptional clarity, insight, and professionalism, delivering meaningful exposure to a highly relevant global audience. This feature significantly elevated our brand visibility and reinforced our position as a leader in life sciences innovation.”

Dr.Barbara Geladakis, MD, Founder and CEO

ResoTher Pharma

“We are thrilled to have been featured in Life Sciences Review Europe, and the reprint they provided has proven to be a game- changer for our marketing strategy. The comprehensive coverage allowed us to communicate our unique value proposition to a wider audience, and the positive response has been overwhelming. The quality of the reprint is top-notch, and it has become a key element in our marketing collateral.”

Anders Kronborg, CEO

EVis Bioscience

“Working with Life Sciences Review Europe’s was a pleasant, smooth, and professional experience. Their team was very supportive and easy to collaborate with. A well-written article highlighting our technology was delivered efficiently, accurately, and on time. We appreciated the opportunity to share EVis Bioscience’s story, and I strongly recommend this magazine to spotlight the ongoing work to improve outcomes.”

Elita Montanari, Co-Founder and CTO

Valentis

“Working with LifeScienceReviewEurope was an exceptional experience; their team was incredibly helpful and consistently went above and beyond the agreed scope of services. We were impressed by their flexibility and willingness to adapt our needs without compromising on quality. I am extremely satisfied with our collaboration.”

Miglė Dilienė, Export Project Manager

Insights From Public Company Thought Leaders